240 related articles for article (PubMed ID: 22322917)
1. Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes.
Vind BF; Birk JB; Vienberg SG; Andersen B; Beck-Nielsen H; Wojtaszewski JF; Højlund K
Diabetologia; 2012 May; 55(5):1435-45. PubMed ID: 22322917
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.
Vaag A; Damsbo P; Hother-Nielsen O; Beck-Nielsen H
Diabetologia; 1992 Jan; 35(1):80-8. PubMed ID: 1541385
[TBL] [Abstract][Full Text] [Related]
3. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
Vestergaard H
Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of muscle glycogen synthase in recovery from exercise in type 2 diabetes.
Pedersen AJ; Hingst JR; Friedrichsen M; Kristensen JM; Højlund K; Wojtaszewski JF
Diabetologia; 2015 Jul; 58(7):1569-78. PubMed ID: 25870023
[TBL] [Abstract][Full Text] [Related]
6. Akt2 influences glycogen synthase activity in human skeletal muscle through regulation of NH₂-terminal (sites 2 + 2a) phosphorylation.
Friedrichsen M; Birk JB; Richter EA; Ribel-Madsen R; Pehmøller C; Hansen BF; Beck-Nielsen H; Hirshman MF; Goodyear LJ; Vaag A; Poulsen P; Wojtaszewski JF
Am J Physiol Endocrinol Metab; 2013 Mar; 304(6):E631-9. PubMed ID: 23321478
[TBL] [Abstract][Full Text] [Related]
7. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes.
Kim YB; Nikoulina SE; Ciaraldi TP; Henry RR; Kahn BB
J Clin Invest; 1999 Sep; 104(6):733-41. PubMed ID: 10491408
[TBL] [Abstract][Full Text] [Related]
8. Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes.
Højlund K; Frystyk J; Levin K; Flyvbjerg A; Wojtaszewski JF; Beck-Nielsen H
Diabetologia; 2006 Jun; 49(6):1283-91. PubMed ID: 16609880
[TBL] [Abstract][Full Text] [Related]
9. Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training.
Vind BF; Pehmøller C; Treebak JT; Birk JB; Hey-Mogensen M; Beck-Nielsen H; Zierath JR; Wojtaszewski JF; Højlund K
Diabetologia; 2011 Jan; 54(1):157-67. PubMed ID: 20938636
[TBL] [Abstract][Full Text] [Related]
10. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
11. Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
Glintborg D; Højlund K; Andersen NR; Hansen BF; Beck-Nielsen H; Wojtaszewski JF
J Clin Endocrinol Metab; 2008 Sep; 93(9):3618-26. PubMed ID: 18544618
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of glycogen synthase COOH- and NH2-terminal phosphorylation by insulin in obesity and type 2 diabetes mellitus.
Højlund K; Birk JB; Klein DK; Levin K; Rose AJ; Hansen BF; Nielsen JN; Beck-Nielsen H; Wojtaszewski JF
J Clin Endocrinol Metab; 2009 Nov; 94(11):4547-56. PubMed ID: 19837931
[TBL] [Abstract][Full Text] [Related]
13. Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.
Mandarino LJ; Consoli A; Kelley DE; Reilly JJ; Nurjhan N
J Clin Endocrinol Metab; 1990 Dec; 71(6):1544-51. PubMed ID: 2121778
[TBL] [Abstract][Full Text] [Related]
14. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
15. In vivo insulin regulation of skeletal muscle glycogen synthase in calorie-restricted and in ad libitum-fed rhesus monkeys.
Ortmeyer HK
J Nutr; 2001 Mar; 131(3):907S-912S. PubMed ID: 11238784
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy.
Haugaard SB; Andersen O; Madsbad S; Frøsig C; Iversen J; Nielsen JO; Wojtaszewski JF
Diabetes; 2005 Dec; 54(12):3474-83. PubMed ID: 16306364
[TBL] [Abstract][Full Text] [Related]
17. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
Vestergaard H; Lund S; Bjørbaek C; Pedersen O
Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
[TBL] [Abstract][Full Text] [Related]
18. Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes.
Højlund K; Staehr P; Hansen BF; Green KA; Hardie DG; Richter EA; Beck-Nielsen H; Wojtaszewski JF
Diabetes; 2003 Jun; 52(6):1393-402. PubMed ID: 12765949
[TBL] [Abstract][Full Text] [Related]
19. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.
Damsbo P; Vaag A; Hother-Nielsen O; Beck-Nielsen H
Diabetologia; 1991 Apr; 34(4):239-45. PubMed ID: 1906024
[TBL] [Abstract][Full Text] [Related]
20. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin.
Damsbo P; Hermann LS; Vaag A; Hother-Nielsen O; Beck-Nielsen H
Diabetes Care; 1998 Sep; 21(9):1489-94. PubMed ID: 9727896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
